IQVIA Social Intelligence Report
Brand Sentiment and Reputation - Rheumatoid Arthritis
White Paper
Aug 07, 2018

Social Intelligence Report - Rheumatoid Arthritis. May, 2018 Edition. Social Intelligence reports are monthly syndicated publications covering one of four specific therapy areas. Each report covers the major pharmaceutical brands in a specific therapy area and monitors the brands over time to provide trend and competitive insights.

In the last five years, there have been 216 million conversations related to rheumatoid arthritis online and on social media. The active RA community online not only engages on social platforms to raise disease awareness, provide emotional support and discuss their disease experiences, but also voices their concerns, treatment-related unmet needs and expectations.

Foundations, advocacy groups, support organizations, patient communities and research groups are a few among the many to be mentioned who drive online conversations and digital initiatives in this area. The treatment landscape indicates that therapies in RA have mainly been aimed at reducing pain, stiffness and stopping the progression of joint destruction.

Most of the existing DMARD’s and biologics that have entered the market have been able to provide remarkable change in disease management and help patients experience longer periods of remission. While doctors often focus on treatment targets, for many patients, control over pain and fatigue, sustaining physical function and quality of life (QoL), is of primary importance.

Patients are commonly noted to express negative sentiment and specific concerns related to side effects while being on therapy that may impact their daily living. Such unmet needs related to their ability to regain function and achieve meaningful QoL could indeed reflect the growing dissatisfaction arising out of misaligned priorities between the patient and their healthcare partners. Thus, listening to the patient voice on social media becomes important as this can supplement interesting insights and create opportunities to markup the patient preferences to biologics therapy in this dynamic treatment landscape. This can also aid in improving patient-centered services.

To learn more about IQVIA Social Listening click here.

 

Download to read more
RELATED SOLUTIONS
Reporting and Analytics

Transform data into action

PharmaReport

Understand your performance...at a glance

You may also be interested in
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.